Sleep Aids in Chile
SLEEP AIDS IN CHILE
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
Mental Diseases Are A National Health Issue
Cannabis As An Alternative Sleep Aid
Grey Utc and Rx Black Market Attract Consumers
Competitive Landscape
Agua Del Carmen Could Take Second Position From Armonyl
Melipass Remains the Dominant Brand
Category Data
Table 1 Sales of Sleep Aids: Value 2013-2018
Table 2 Sales of Sleep Aids: % Value Growth 2013-2018
Table 3 NBO Company Shares of Sleep Aids: % Value 2014-2018
Table 4 LBN Brand Shares of Sleep Aids: % Value 2015-2018
Table 5 Forecast Sales of Sleep Aids: Value 2018-2023
Table 6 Forecast Sales of Sleep Aids: % Value Growth 2018-2023
Executive Summary
Consumer Health, A Challenging Market That Needs To Conciliate Legislative Framework and More Exigent Consumers
Consumer Health Remains Healthy
Who Owns the Consumer?
the Perfect Storm for Internet Selling
Prevention Over Treatment, the Split of Consumer Health Future
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 8 Life Expectancy at Birth 2013-2018
Market Data
Table 9 Sales of Consumer Health by Category: Value 2013-2018
Table 10 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 11 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 12 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 14 Distribution of Consumer Health by Format: % Value 2013-2018
Table 15 Distribution of Consumer Health by Format and Category: % Value 2018
Table 16 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches
Definitions
Sources
Summary 2 Research Sources
Incidences of mental health disorder in Chile are among the highest in the world, with a depression prevalence of 17% of the population and the first sick-day reason in Chile is psychiatric issues. At the end of the review period, three of the 80 disorders included in the national health programme (AUGE) were psychiatric – depression, bipolarity and schizophrenia.
Euromonitor International's Sleep Aids in Chile report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Sleep Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.